about
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell...
Read More
2.08
0.02
(0.97%)
343.9K
XNAS Volume
XNAS 02 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Mural Oncology plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..